UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma

Cancer Cell

Volumn 25, Issue 2, 2014, Pages 196-209

  Mudbhary, Raksha ^a   Hoshida, Yujin ^a   Chernyavskaya, Yelena ^a   Jacob, Vinitha ^a   Villanueva, Augusto ^b,c   Fiel, M Isabel ^a   Chen, Xintong ^a   Kojima, Kensuke ^a   Thung, Swan ^a   Bronson, RoderickT ^d   Lachenmayer, Anja ^a   Revill, Kate ^a   Alsinet, Clara ^b   Sachidanandam, Ravi ^a   Desai, Anal ^d   SenBanerjee, Sucharita ^d   Ukomadu, Chinweike ^d   Llovet, JosepM ^a,b,e   Sadler, KirstenC ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CANCER CELL; DNA METHYLATION; GENE; GENE OVEREXPRESSION; LIVER CELL; LIVER CELL CARCINOMA; MUTATOR GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SENESCENCE; TP53 GENE; UBIQUITIN LIKE WITH PHD AND RING FINGER DOMAIN 1 GENE; UPREGULATION; ZEBRA FISH;

DANIO RERIO;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEINS; CELL AGING; CELLS, CULTURED; COHORT STUDIES; COMPUTATIONAL BIOLOGY; DNA METHYLATION; HEPATOCYTES; HUMANS; IMMUNOBLOTTING; LIVER; LIVER NEOPLASMS; MUTATION; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; ZEBRAFISH;

EID: 84893758816     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2014.01.003     Document Type: Article

References (63)

1. Anderson R.M., Bosch J.A., Goll M.G., Hesselson D., Dong P.D., Shin D., Chi N.C., Shin C.H., Schlegel A., Halpern M., Stainier D.Y. Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev. Biol. 2009, 334:213-223.
2. Arita K., Ariyoshi M., Tochio H., Nakamura Y., Shirakawa M. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008, 455:818-821.
3. Avvakumov G.V., Walker J.R., Xue S., Li Y., Duan S., Bronner C., Arrowsmith C.H., Dhe-Paganon S. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 2008, 455:822-825.
4. Babbio F., Pistore C., Curti L., Castiglioni I., Kunderfranco P., Brino L., Oudet P., Seiler R., Thalman G.N., Roggero E., et al. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene 2012, 31:4878-4887.
5. Berdasco M., Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell 2010, 19:698-711.
6. Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. USA 2005, 102:407-412.
7. Biniszkiewicz D., Gribnau J., Ramsahoye B., Gaudet F., Eggan K., Humpherys D., Mastrangelo M.A., Jun Z., Walter J., Jaenisch R. Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol. Cell. Biol. 2002, 22:2124-2135.
8. Bostick M., Kim J.K., Estève P.O., Clark A., Pradhan S., Jacobsen S.E. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007, 317:1760-1764.
9. Calvisi D.F., Ladu S., Gorden A., Farina M., Lee J.S., Conner E.A., Schroeder I., Factor V.M., Thorgeirsson S.S. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J.Clin. Invest. 2007, 117:2713-2722.
10. Cheah M.S., Wallace C.D., Hoffman R.M. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J.Natl. Cancer Inst. 1984, 73:1057-1065.
11. Chen T., Hevi S., Gay F., Tsujimoto N., He T., Zhang B., Ueda Y., Li E. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat. Genet. 2007, 39:391-396.
12. Chiang D.Y., Villanueva A., Hoshida Y., Peix J., Newell P., Minguez B., LeBlanc A.C., Donovan D.J., Thung S.N., Solé M., et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res. 2008, 68:6779-6788.
13. Chu J., Loughlin E.A., Gaur N.A., SenBanerjee S., Jacob V., Monson C., Kent B., Oranu A., Ding Y., Ukomadu C., Sadler K.C. UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis. Mol. Biol. Cell 2012, 23:59-70.
14. Chu J., Mir A., Gao N., Rosa S., Monson C., Sharma V., Steet R., Freeze H.H., Lehrman M.A., Sadler K.C. A zebrafish model of congenital disorders of glycosylation with phosphomannose isomerase deficiency reveals an early opportunity for corrective mannose supplementation. Dis. Model. Mech. 2013, 6:95-105.
15. Decottignies A., d'Adda di Fagagna F. Epigenetic alterations associated with cellular senescence: a barrier against tumorigenesis or a red carpet for cancer?. Semin. Cancer Biol. 2011, 21:360-366.
16. Di Micco R., Sulli G., Dobreva M., Liontos M., Botrugno O.A., Gargiulo G., dal Zuffo R., Matti V., d'Ario G., Montani E., et al. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat. Cell Biol. 2011, 13:292-302.
17. Du Z., Song J., Wang Y., Zhao Y., Guda K., Yang S., Kao H.Y., Xu Y., Willis J., Markowitz S.D., et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination. Sci. Signal. 2010, 3:ra80.
18. Eden A., Gaudet F., Waghmare A., Jaenisch R. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 2003, 300:455.
19. Fairweather D.S., Fox M., Margison G.P. The invitro lifespan of MRC-5 cells is shortened by 5-azacytidine-induced demethylation. Exp. Cell Res. 1987, 168:153-159.
20. Feng S., Cokus S.J., Zhang X., Chen P.Y., Bostick M., Goll M.G., Hetzel J., Jain J., Strauss S.H., Halpern M.E., et al. Conservation and divergence of methylation patterning in plants and animals. Proc. Natl. Acad. Sci. USA 2010, 107:8689-8694.
21. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
22. Gaudet F., Rideout W.M., Meissner A., Dausman J., Leonhardt H., Jaenisch R. Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing. Mol. Cell. Biol. 2004, 24:1640-1648.
23. Hashimoto H., Horton J.R., Zhang X., Bostick M., Jacobsen S.E., Cheng X. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 2008, 455:826-829.
24. Hoshida Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 2010, 5:e15543.
25. Howard G., Eiges R., Gaudet F., Jaenisch R., Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008, 27:404-408.
26. Imrie D., Sadler K.C. White adipose tissue development in zebrafish is regulated by both developmental time and fish size. Dev. Dyn. 2010, 239:3013-3023.
27. Jackson-Grusby L., Beard C., Possemato R., Tudor M., Fambrough D., Csankovszki G., Dausman J., Lee P., Wilson C., Lander E., Jaenisch R. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat. Genet. 2001, 27:31-39.
28. Jin W., Chen L., Chen Y., Xu S.G., Di G.H., Yin W.J., Wu J., Shao Z.M. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res. Treat. 2010, 123:359-373.
29. Jirtle R.L. IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. Gastroenterology 2004, 126:1190-1193.
30. Karpf A.R., Matsui S. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res. 2005, 65:8635-8639.
31. Karpf A.R., Moore B.C., Ririe T.O., Jones D.A. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine. Mol. Pharmacol. 2001, 59:751-757.
32. Kwan K.M., Fujimoto E., Grabher C., Mangum B.D., Hardy M.E., Campbell D.S., Parant J.M., Yost H.J., Kanki J.P., Chien C.B. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev. Dyn. 2007, 236:3088-3099.
33. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993, 366:362-365.
34. Liu X., Gao Q., Li P., Zhao Q., Zhang J., Li J., Koseki H., Wong J. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat. Commun. 2013, 4:1563.
35. Llovet J.M., Burroughs A., Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917.
36. Llovet J.M., Chen Y., Wurmbach E., Roayaie S., Fiel M.I., Schwartz M., Thung S.N., Khitrov G., Zhang W., Villanueva A., et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology 2006, 131:1758-1767.
37. Llovet J.M., Ricci S., Mazzaferro V., Hilgard P., Gane E., Blanc J.F., de Oliveira A.C., Santoro A., Raoul J.L., Forner A., et al. Sorafenib in advanced hepatocellular carcinoma. N.Engl. J. Med. 2008, 359:378-390. SHARP Investigators Study Group.
38. Lujambio A., Akkari L., Simon J., Grace D., Tschaharganeh D.F., Bolden J.E., Zhao Z., Thapar V., Joyce J.A., Krizhanovsky V., Lowe S.W. Non-cell-autonomous tumor suppression by p53. Cell 2013, 153:449-460.
39. McDuff F.K., Turner S.D. Jailbreak: oncogene-induced senescence and its evasion. Cell. Signal. 2011, 23:6-13.
40. Mudbhary R., Sadler K.C. Epigenetics, development, and cancer: zebrafish make their mark. Birth Defects Res. C Embryo Today 2011, 93:194-203.
41. Nishiyama A., Yamaguchi L., Sharif J., Johmura Y., Kawamura T., Nakanishi K., Shimamura S., Arita K., Kodama T., Ishikawa F., et al. Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication. Nature 2013, 502:249-253.
42. Pogribny I.P., Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2014, 342:223-230.
43. Qin W., Leonhardt H., Spada F. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. J.Cell. Biochem. 2011, 112:439-444.
44. Rai K., Nadauld L.D., Chidester S., Manos E.J., James S.R., Karpf A.R., Cairns B.R., Jones D.A. Zebra fish Dnmt1 and Suv39h1 regulate organ-specific terminal differentiation during development. Mol. Cell. Biol. 2006, 26:7077-7085.
45. Rai K., Sarkar S., Broadbent T.J., Voas M., Grossmann K.F., Nadauld L.D., Dehghanizadeh S., Hagos F.T., Li Y., Toth R.K., et al. DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell 2010, 142:930-942.
46. Sadler K.C., Amsterdam A., Soroka C., Boyer J., Hopkins N. A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development 2005, 132:3561-3572.
47. Sadler K.C., Krahn K.N., Gaur N.A., Ukomadu C. Liver growth in the embryo and during liver regeneration in zebrafish requires the cell cycle regulator, uhrf1. Proc. Natl. Acad. Sci. USA 2007, 104:1570-1575.
48. Sharif J., Muto M., Takebayashi S., Suetake I., Iwamatsu A., Endo T.A., Shinga J., Mizutani-Koseki Y., Toyoda T., Okamura K., et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007, 450:908-912.
49. Tang X., Milyavsky M., Goldfinger N., Rotter V. Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress. Oncogene 2007, 26:7302-7312.
50. Taylor E.M., Bonsu N.M., Price R.J., Lindsay H.D. Depletion of Uhrf1 inhibits chromosomal DNA replication in Xenopus egg extracts. Nucleic Acids Res. 2013, 41:7725-7737.
51. Tien A.L., Senbanerjee S., Kulkarni A., Mudbhary R., Goudreau B., Ganesan S., Sadler K.C., Ukomadu C. UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochem. J. 2011, 435:175-185.
52. Tischoff I., Tannapfe A. DNA methylation in hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:1741-1748.
53. Tittle R.K., Sze R., Ng A., Nuckels R.J., Swartz M.E., Anderson R.M., Bosch J., Stainier D.Y., Eberhart J.K., Gross J.M. Uhrf1 and Dnmt1 are required for development and maintenance of the zebrafish lens. Dev. Biol. 2011, 350:50-63.
54. Unoki M., Daigo Y., Koinuma J., Tsuchiya E., Hamamoto R., Nakamura Y. UHRF1 is a novel diagnostic marker of lung cancer. Br. J. Cancer 2010, 103:217-222.
55. Ventura A., Kirsch D.G., McLaughlin M.E., Tuveson D.A., Grimm J., Lintault L., Newman J., Reczek E.E., Weissleder R., Jacks T. Restoration of p53 function leads to tumour regression invivo. Nature 2007, 445:661-665.
56. Villanueva A., Chiang D.Y., Newell P., Peix J., Thung S., Alsinet C., Tovar V., Roayaie S., Minguez B., Sole M., et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology 2008, 135:1972-1983.
57. Villanueva A., Hoshida Y., Battiston C., Tovar V., Sia D., Alsinet C., Cornella H., Liberzon A., Kobayashi M., Kumada H., et al. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011, 140:1501-1512.
58. Wang F., Yang Y.Z., Shi C.Z., Zhang P., Moyer M.P., Zhang H.Z., Zou Y., Qin H.L. UHRF1 promotes cell growth and metastasis through repression of p16(ink4a) in colorectal cancer. Ann. Surg. Oncol. 2012, 19:2753-2762.
59. Weber M., Schübeler D. Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr. Opin. Cell Biol. 2007, 19:273-280.
60. Wurmbach E., Chen Y.B., Khitrov G., Zhang W., Roayaie S., Schwartz M., Fiel I., Thung S., Mazzaferro V., Bruix J., et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007, 45:938-947.
61. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660.
62. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H., Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA 2005, 102:13580-13585.
63. You J.S., Jones P.A. Cancer genetics and epigenetics: two sides of the same coin?. Cancer Cell 2012, 22:9-20.